Malarial Antigen Detection

Bacterial/ Viral

Report in 4Hrs

At Home

No Fasting Required

Details

Detects Plasmodium parasites in blood; used to confirm malaria diagnosis.

₹169₹700

76% OFF

Malarial Antigen Detection - Comprehensive Medical Test Guide

Why is it done?
- Detects specific antigens produced by Plasmodium parasites (P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi) in blood samples
- Rapid diagnosis of malaria infection in patients presenting with fever and compatible symptoms
- Identification of specific Plasmodium species to guide appropriate antimalarial treatment selection
- Screening of blood donors and pregnant women in endemic areas to prevent transfusion-transmitted and congenital malaria
- Primary indications include: unexplained fever in travelers returning from endemic regions, symptomatic patients in malaria-prone areas, fever of unknown origin, and suspected severe malaria
- Typically performed within 24 hours of symptom onset for optimal sensitivity; can be repeated if initial test is negative but clinical suspicion remains high
Normal Range
- Normal Result: NEGATIVE - No malarial antigens detected in blood sample
- Units of Measurement: Qualitative (Positive/Negative or Negative/1+ to 4+ depending on assay methodology and parasitemia levels)
- Test Interpretation: Negative indicates absence of detectable malarial antigens and suggests no active malaria infection, though early-stage infections with low parasitemia may be missed
- Reference Ranges: Most rapid diagnostic tests (RDTs) are qualitative with sensitivity ranging from 95-99% and specificity from 94-99% depending on the Plasmodium species and parasitemia levels
- Microscopic examination (if performed): Parasite density reported as parasites per microliter (μL) of blood; normal is 0 parasites/μL
Interpretation
- Positive Result (Malarial Antigens Detected):
  - Indicates active malarial infection with viable parasites present in the bloodstream
  - Species-specific positive results identify the Plasmodium species (falciparum, vivax, ovale, malariae, knowlesi) enabling targeted treatment decisions
  - Intensity of antigen detection may correlate with parasitemia levels: higher intensity suggests greater parasite burden
  - Requires immediate initiation of antimalarial therapy based on identified species and local resistance patterns
- Negative Result (No Malarial Antigens Detected):
  - Suggests absence of active malarial infection at the time of testing
  - However, negative result does not completely exclude malaria: early infections (pre-parasitemia stage), very low parasitemia levels, or gametocyte-only infections may not be detected
  - Repeat testing may be warranted if clinical suspicion remains high (WHO recommends up to 3 negative tests before excluding malaria)
- Factors Affecting Results:
  - Parasitemia level: Very low parasitemia (<40 parasites/μL) may evade detection
  - Stage of infection: Gametocyte-predominant infections may be difficult to detect with antigen-based tests
  - Specimen quality: Hemolyzed, clotted, or contaminated samples may yield false results
  - Recent antimalarial treatment: May result in false negatives if testing performed shortly after treatment initiation
  - Assay type and sensitivity: Different RDT brands have varying sensitivities (75-99%) and specificities (94-99%)
  - Multiple infections: Co-infections with multiple Plasmodium species may complicate interpretation
- Clinical Significance:
  - Rapid diagnostic tests are WHO-recommended first-line diagnostics for malaria due to speed and accessibility
  - Species identification guides treatment selection: P. falciparum and P. knowlesi require artemisinin-based combination therapy (ACT), while P. vivax and P. ovale require hypnozoite-targeting agents
  - Results should ideally be confirmed with microscopy or quantitative PCR, especially in low-parasitemia settings or for quantification purposes
  - Positive result in endemic areas indicates acute malaria requiring treatment; in non-endemic areas suggests imported malaria
Associated Organs
- Primary Organ Systems Involved:
  - Hematologic System: Parasites infect and lyse red blood cells, causing hemolytic anemia
  - Hepatic System: Parasites replicate in hepatocytes during pre-erythrocytic stage; primary site of initial parasitemia
  - Cardiovascular System: Affected by severe anemia, hyperparasitemia, and metabolic acidosis
  - Central Nervous System: Cerebral malaria results from sequestration of infected RBCs and inflammatory cytokine release
  - Renal System: Acute kidney injury may develop from hemolysis, DIC, and hypovolemia in severe malaria
- Associated Diseases and Conditions:
  - Uncomplicated Malaria: Fever, chills, headache, myalgias, and malaise typically in cyclical patterns
  - Severe Malaria: Cerebral malaria, severe anemia, acute kidney injury, pulmonary edema, severe metabolic acidosis, hypoglycemia, and DIC
  - P. falciparum Malaria: Most severe form; highest risk for complications and mortality if untreated
  - P. vivax/P. ovale Malaria: Latent hypnozoites can cause relapses weeks to months after initial infection
  - Congenital Malaria: Vertical transmission to neonates causing severe disease and mortality
  - Transfusion-transmitted Malaria: Acquisition through contaminated blood products
- Potential Complications from Abnormal Results:
  - Delayed diagnosis increases mortality risk, especially in P. falciparum infections where mortality without treatment can exceed 20%
  - Severe anemia requiring transfusion support, with associated transfusion risks
  - Cerebral malaria with risk of permanent neurological sequelae, cognitive impairment, and death
  - Acute kidney injury requiring dialysis and associated with higher mortality
  - Acute respiratory distress syndrome and pulmonary edema necessitating mechanical ventilation
  - Disseminated intravascular coagulation with bleeding complications and multi-organ failure
  - Pregnancy complications including placental sequestration, maternal anemia, preterm labor, and fetal loss
Follow-up Tests
- Confirmatory and Species Identification Tests:
  - Peripheral Blood Smear Microscopy: Gold standard for confirmation and species identification; also determines parasitemia density
  - Real-time Quantitative PCR (qPCR): Highly sensitive and specific; can quantify parasitemia and detect mixed infections; used for research and in resource-rich settings
  - Nested PCR: More sensitive than single PCR, particularly for detecting low parasitemia levels
- Monitoring and Severity Assessment Tests:
  - Complete Blood Count (CBC): Assess hemoglobin levels for anemia severity, platelet counts for thrombocytopenia
  - Liver Function Tests (LFTs): AST, ALT, bilirubin to assess hepatic involvement and dysfunction
  - Renal Function Tests: Serum creatinine, urea, and electrolytes to evaluate acute kidney injury risk
  - Blood Glucose: Screen for hypoglycemia, particularly important in severe malaria
  - Blood Lactate: Elevated levels indicate metabolic acidosis and severe malaria
  - Coagulation Profile (PT/INR, aPTT): Screen for DIC in severe malaria
- Imaging and Additional Investigations:
  - Cerebral Spinal Fluid Analysis: If cerebral malaria or meningitis suspected
  - Chest X-ray: Evaluate for acute respiratory distress syndrome or pulmonary edema in severe malaria
  - Blood Culture: Rule out concurrent bacterial sepsis if indicated
- Monitoring Frequency During Treatment:
  - Follow-up RDT or Blood Smear: Day 3, 7, and 28 post-treatment to assess treatment response and parasitemia clearance
  - Repeat CBC: Monitor for recovery of hemoglobin and platelet counts, typically improving within 2-4 weeks
  - Repeat LFTs and Renal Function: Monitor for normalization, especially in complicated malaria
  - Post-treatment Follow-up at Day 28: Essential to detect treatment failures or recrudescence, particularly important for P. falciparum
- Post-Treatment Relapse Monitoring (P. vivax and P. ovale):
  - Parasitemia Monitoring: At any fever episode within 1 year (up to 3 years for P. ovale) post-treatment
  - Regular RDT or microscopy for relapse surveillance in endemic areas or high-risk populations
Fasting Required?
- Fasting Status: NO - Fasting is NOT required for malarial antigen detection testing
- Patient can eat and drink normally before blood collection for this test
Patient Preparation Requirements:
- Blood sample collection: Can be performed at any time of day, though parasitemia may fluctuate with fever cycles; some parasites (P. malariae and P. ovale) are more abundant in morning blood
- Medications: NO specific medications need to be avoided prior to testing; antimalarial drugs or other medications do not affect antigen detection accuracy
- Specimen collection: Standard venipuncture performed to collect 2-3 mL of blood in EDTA tube (lavender-top) for RDT or microscopy
- Sample handling: Samples should be processed promptly (within 1-2 hours for RDT); delayed processing may reduce sensitivity
- For multiple tests: If additional lab work is required (CBC, LFTs, RFTs), collection may be performed simultaneously as antigen testing
- Repeat testing: If initial test is negative but clinical suspicion remains high, repeat sampling should be performed 12-24 hours later (WHO recommends 3 negative tests over 48 hours to exclude malaria)
- No special skin preparation: Standard antiseptic preparation with 70% isopropyl alcohol or chlorhexidine sufficient
- Fever status: Testing can be performed regardless of current fever presence; febrile episodes not required, though parasitemia may be higher during fever

How our test process works!